VC-backed Egalet Corp files for $61 mln IPO – Fortune

Egalet Corp has filed for a $61 million IPO, Fortune reported. According to the publication, the company plans to list the stock on the NASDAQ under the ticker symbol “EGLT.” Stifel and JMP Securities will act as lead underwriters. Based in Malvern, Penn., Egalet is a specialty pharma company focusing on pain management. Investors include Atlas Ventures, Danish Biotech, Sunstone Capital, Index Ventures and Enso Ventures.